Table 1 Patient and tumor characteristics
From: Impact of neuroradiologist second opinion on staging and management of head and neck cancer
| Â | All cases | Surgical cases |
|---|---|---|
Variable | (n = 94) | (n = 30) |
Age (y), mean (range) | 61.6 (31.1, 90.1) | 65.2 (36.3, 89.7) |
Gender (M:F) | 70:24 | 17:13 |
Primary | Â | Â |
 Oral Cavity | 24 (25.5%) | 19 (63.3%) |
 Oropharynx | 22 (23.4%) | 2 (6.7%) |
 Hypopharynx | 2 (2.1%) | 0 (0.0%) |
 Larynx | 15 (16.0%) | 3 (10.0%) |
 Salivary Gland | 6 (6.4%) | 3 (10.0%) |
 NC & PNS | 5 (5.3%) | 2 (6.7%) |
 Nasopharynx | 7 (7.4%) | 0 (0.0%) |
 Thyroid | 1 (1.1%) | 0 (0.0%) |
 Unknown | 5 (5.3%) | 0 (0.0%) |
 Skin | 4 (4.3%) | 1 (3.3%) |
 Lymphoma | 3 (3.2%) | 0 (0.0%) |
Stage | Â | Â |
 Benign | 2 (2.1%) | 1 (3.3%) |
 Stage 0 | 3 (3.2%) | 2 (6.7%) |
 Stage I | 9 (9.6%) | 4 (13.3%) |
 Stage II | 3 (3.2%) | 2 (6.7%) |
 Stage III | 9 (9.6%) | 3 (10.0%) |
 Stage IV | 68 (72.3%) | 18 (60.0%) |